Prosthetic Pelvic Organ Prolapse Repair (PROSPERE)

April 17, 2026 updated by: University Hospital, Lille

Randomized Study Comparing Laparoscopic Sacropexy and Vaginal Mesh Surgery in Cystocele Repair

The cystocele is the most frequent clinical shape of the genital prolapse. It is a frequent pathology in woman which can impair quality of life and generates pelvic, urinary or sexual functional disorders.

It's considered that 8 % of women will be undergo surgery in this indication before the age of 80 years. Numerous surgical techniques have been described and we distinguish the interventions according to the route (vaginal or abdominal), and according to the use or not of synthetic mesh (non-absorbable) to increase the anatomical results.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a multicenter, randomized, comparative, 2-parallel-arm study in patients with pelvic organ prolapse (cystocele) Approximately 260 patients aged from 45 to 75 years will be allocated to have laparoscopic sacropexy or vaginal mesh surgery.

Study Type

Interventional

Enrollment (Actual)

262

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Annecy, France, 74374
        • Sébatien BLANC
      • Clamart, France, 92140
        • Hôpital Antoine Béclère
      • Clermont-Ferrand, France, 63003
        • Chu Estaing
      • Grande-Synthe, France, 59760
        • GCS Flandre Maritime
      • La Rochelle, France, 17019
        • CH La Rochelle Service de Gynécologie Obstétrique
      • Le Kremlin-Bicêtre, France, 94275
        • Hôpital BICETRE / Service de Gynécologie Obstétrique
      • Lille, France, 59037
        • CHRU de Lille - Service de Gynécologie médico chirurgicale
      • Nîmes, France, 30029
        • CHU de Nîmes
      • Paris, France, 75571
        • Groupe Hospitalier Diaconesses Croix St-Simon
      • Poissy, France, 78303
        • CHI Poissy-St-Germain / Service de gynécologie
      • Poitiers, France, 86000
        • Chu de Poitiers
      • Strasbourg, France, 67000
        • Hopital de Hautepierre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Cystocele superior or equal to stage II of the international classification POP-Q, isolated or associated with other elements of prolapse.
  • Patient must have provided written informed consent form prior to enrolment
  • Patient must be insured

Exclusion Criteria:

  • Previous of surgery for prolapse
  • Unfavourable conditions to one or other of the 2 evaluated procedure
  • Pelvic malignancy in the course of evolution
  • Contraindication to the use of mesh
  • Women not reading French
  • Patients haven't have a social insurance
  • Pregnancy or desire for future pregnancy
  • To be under guardianship or deprived of liberty
  • Simultaneous participation in another biomedical research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: laparoscopic sacropexy
under laparoscopic vision, the vesico-vaginal space is dissected until the level of the bladder neck. a synthetic non absorbable mesh is placed between the bladder and the vagina. the mesh is sutured to the vagina and the apex (vaginal apex or uterus) and anchored to the prevertebral ligament in front of the promontorium.
under laparoscopic vision, the vesico-vaginal space is dissected until the level of the bladder neck. a synthetic non absorbable mesh is placed between the bladder and the vagina. the mesh is sutured to the vagina and the apex (vaginal apex or uterus) and anchored to the prevertebral ligament in front of the promontorium.
Other Names:
  • laparoscopic surgery
Experimental: vaginal mesh
after anterior sagittal colpotomy, the bladder is dissected under the fascia layer, and the paravesical fossa are entered. a synthetic non absorbable mesh is placed with 4 arms suspension (trans obturator or not). treatment of the apex is mandatory.
after anterior sagittal colpotomy, the bladder is dissected under the fascia layer, and the paravesical fossa are entered. a synthetic non absorbable mesh is placed with 4 arms suspension (trans obturator or not). treatment of the apex is mandatory.
Other Names:
  • medical vaginal device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Morbidity (Dindo Classification)
Time Frame: 12 months
Compare the morbidity of the sub-vesical synthetic mesh according to the route between laparoscopic sacropexy or vaginal in the symptomatic superior stage II cystoceles at 1 year follow-up.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Specific complications
Time Frame: 12 months

Comparison for the specific complications of sub-vesical mesh according to the route :

  • Symptomatic erosions, shrinkages, infections,
  • Serious Adverse event
12 months
Medium-term tolerance
Time Frame: 12 months

Comparison of both techniques for the medium-term tolerance:

  • Sexual: sexual quality of life, de novo dyspareunia;
  • Urinary: urinary quality of life, urinary functional signs, urgenturia, leakage
  • Post-operative chronic pelvic pains
12 months
Clinical Efficiency
Time Frame: 12 months

Comparison of both techniques for the medium-term (1 year follow-up)clinical efficiency:

  • rate of anatomical recurrences at one year,
  • functional Symptoms of prolapse, general quality of life
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean-Philippe LUCOT, MD, CHRU de Lille

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

November 1, 2015

Study Registration Dates

First Submitted

July 6, 2012

First Submitted That Met QC Criteria

July 6, 2012

First Posted (Estimated)

July 11, 2012

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

November 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cystocele

Clinical Trials on laparoscopic sacropexy

Subscribe